• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

自身免疫性肝炎患者的癌症风险:一项基于人群的全国队列研究与组织病理学。

Cancer Risk in Patients With Autoimmune Hepatitis: A Nationwide Population-Based Cohort Study With Histopathology.

出版信息

Am J Epidemiol. 2022 Jan 24;191(2):298-319. doi: 10.1093/aje/kwab119.

DOI:10.1093/aje/kwab119
PMID:33913487
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8897999/
Abstract

We aimed to determine the risk of incident cancer in autoimmune hepatitis (AIH) compared with the general population and siblings. AIH was defined by the presence of a medical diagnosis of AIH and results of examination of a liver biopsy specimen in a nationwide Swedish population-based cohort study. We identified 5,268 adults with AIH diagnosed during 1969-2016 and 22,996 matched, general population, reference individuals and 4,170 sibling comparators. Using Cox regression, hazard ratios were determined for any incident cancer, and subtypes were determined from the Swedish Cancer Register. During follow-up, a cancer diagnosis was made in 1,119 individuals with AIH (17.2 per 1,000 person-years) and 4,450 reference individuals (12.0 per 1,000 person-years). This corresponded to a hazard ratio of 1.53 (95% confidence interval: 1.42, 1.66). Cancer risk was highest in those with cirrhosis. There was a 29.18-fold increased risk of hepatocellular carcinoma (HCC) (95% confidence interval: 17.52, 48.61). The annual incidence risk of HCC in individuals with AIH who had cirrhosis was 1.1% per year. AIH was also linked to nonmelanoma skin cancer (hazard ratio (HR) = 2.69) and lymphoma (HR = 1.89). Sibling analyses yielded similar risk estimates for any cancer (HR = 1.84) and HCC (HR = 23.10). AIH is associated with an increased risk of any cancer, in particular, HCC and extrahepatic malignancies. The highest risk for cancer, especially HCC, is in patients with cirrhosis.

摘要

我们旨在确定自身免疫性肝炎 (AIH) 患者与普通人群和兄弟姐妹相比发生癌症的风险。AIH 是通过全国性瑞典人群队列研究中存在医学诊断 AIH 和肝活检标本检查结果来定义的。我们确定了 1969 年至 2016 年间诊断出的 5268 名成年人 AIH 患者和 22996 名匹配的普通人群、参考个体和 4170 名兄弟姐妹对照者。使用 Cox 回归,确定了任何癌症的风险比,并且从瑞典癌症登记处确定了癌症亚型。在随访期间,1119 名 AIH 患者(17.2 人/千人年)和 4450 名参考个体(12.0 人/千人年)被诊断出患有癌症,这相当于风险比为 1.53(95%置信区间:1.42,1.66)。在肝硬化患者中,癌症风险最高。肝细胞癌(HCC)的风险增加了 29.18 倍(95%置信区间:17.52,48.61)。患有肝硬化的 AIH 患者的 HCC 年发病率风险为 1.1%。AIH 还与非黑色素瘤皮肤癌(风险比(HR)=2.69)和淋巴瘤(HR=1.89)有关。同胞分析得出了任何癌症(HR=1.84)和 HCC(HR=23.10)的相似风险估计值。AIH 与任何癌症的风险增加相关,特别是 HCC 和肝外恶性肿瘤。患有肝硬化的患者发生癌症的风险最高,特别是 HCC。

相似文献

1
Cancer Risk in Patients With Autoimmune Hepatitis: A Nationwide Population-Based Cohort Study With Histopathology.自身免疫性肝炎患者的癌症风险:一项基于人群的全国队列研究与组织病理学。
Am J Epidemiol. 2022 Jan 24;191(2):298-319. doi: 10.1093/aje/kwab119.
2
Hepatocellular and extrahepatic cancer in patients with autoimmune hepatitis--a long-term follow-up study in 634 Swedish patients.自身免疫性肝炎患者的肝细胞癌和肝外癌——对634名瑞典患者的长期随访研究
Scand J Gastroenterol. 2015 Feb;50(2):217-23. doi: 10.3109/00365521.2014.983154. Epub 2014 Dec 8.
3
Incidence and predictors of hepatocellular carcinoma in patients with autoimmune hepatitis.自身免疫性肝炎患者肝细胞癌的发病率及预测因素
J Hepatol. 2024 Jan;80(1):53-61. doi: 10.1016/j.jhep.2023.09.010. Epub 2023 Oct 5.
4
Increased Mortality Risk in Autoimmune Hepatitis: A Nationwide Population-Based Cohort Study With Histopathology.自身免疫性肝炎患者的死亡风险增加:一项基于人群的全国性队列研究及肝组织病理分析。
Clin Gastroenterol Hepatol. 2021 Dec;19(12):2636-2647.e13. doi: 10.1016/j.cgh.2020.10.006. Epub 2020 Oct 14.
5
Sex and regional disparities in incidence of hepatocellular carcinoma in autoimmune hepatitis: a systematic review and meta-analysis.自身免疫性肝炎中肝细胞癌发病率的性别和地域差异:系统评价和荟萃分析。
Hepatol Int. 2021 Dec;15(6):1413-1420. doi: 10.1007/s12072-021-10249-9. Epub 2021 Sep 3.
6
Incidence and Determinants of Hepatocellular Carcinoma in Autoimmune Hepatitis: A Systematic Review and Meta-analysis.自身免疫性肝炎中肝细胞癌的发病率及决定因素:一项系统评价与荟萃分析
Clin Gastroenterol Hepatol. 2017 Aug;15(8):1207-1217.e4. doi: 10.1016/j.cgh.2017.02.006. Epub 2017 Feb 12.
7
Increased Cancer Risk in Autoimmune Hepatitis: A Danish Nationwide Cohort Study.自身免疫性肝炎的癌症风险增加:一项丹麦全国队列研究。
Am J Gastroenterol. 2022 Jan 1;117(1):129-137. doi: 10.14309/ajg.0000000000001525.
8
Hepatic and Extrahepatic Characteristics of Autoimmune Hepatitis: A 23-year Hospital-Based Cohort Study.自身免疫性肝炎的肝内和肝外特征:一项基于 23 年医院队列研究。
Dig Dis Sci. 2024 Jun;69(6):2193-2203. doi: 10.1007/s10620-024-08439-0. Epub 2024 Apr 23.
9
Development of hepatocellular carcinoma in autoimmune hepatitis patients: a case series.自身免疫性肝炎患者发生肝细胞癌:病例系列研究。
Dig Dis Sci. 2011 Feb;56(2):578-85. doi: 10.1007/s10620-010-1444-6. Epub 2010 Nov 3.
10
Hepatocellular carcinoma in patients with autoimmune hepatitis.自身免疫性肝炎患者的肝细胞癌
World J Gastroenterol. 2009 Feb 7;15(5):578-82. doi: 10.3748/wjg.15.578.

引用本文的文献

1
Survey of practices of handling exposure measurement errors in modern epidemiology: are the best practices in statistics being adopted by epidemiologists?现代流行病学中暴露测量误差处理方法的调查:流行病学家是否采用了最佳统计方法?
BMC Med Res Methodol. 2025 Aug 25;25(1):198. doi: 10.1186/s12874-025-02651-w.
2
Contemporary epidemiology of hepatocellular carcinoma: understanding risk factors and surveillance strategies.肝细胞癌的当代流行病学:了解风险因素和监测策略。
J Can Assoc Gastroenterol. 2024 Aug 9;7(5):331-345. doi: 10.1093/jcag/gwae025. eCollection 2024 Oct.
3
Impact of metabolic dysfunction-associated steatotic liver disease on hepatocellular carcinoma risk in autoimmune hepatitis.代谢功能障碍相关脂肪性肝病对自身免疫性肝炎患者肝细胞癌风险的影响。
PLoS One. 2025 Jul 22;20(7):e0325066. doi: 10.1371/journal.pone.0325066. eCollection 2025.
4
Identification of B cell antigens in solid cancer: initial insights and functional implications.实体癌中B细胞抗原的鉴定:初步见解与功能意义
Front Immunol. 2025 Apr 28;16:1571570. doi: 10.3389/fimmu.2025.1571570. eCollection 2025.
5
Risk of hepatocellular carcinoma and cirrhosis decompensation in a large retrospective cohort of cirrhotic patients with autoimmune hepatitis.一大群自身免疫性肝炎肝硬化患者的回顾性队列中肝细胞癌和肝硬化失代偿的风险
Sci Rep. 2025 Apr 16;15(1):13212. doi: 10.1038/s41598-025-96342-7.
6
British Society of Gastroenterology guidelines for diagnosis and management of autoimmune hepatitis.英国胃肠病学会自身免疫性肝炎诊断与管理指南
Gut. 2025 Aug 7;74(9):1364-1409. doi: 10.1136/gutjnl-2024-333171.
7
Increased Risk of Non-Hodgkin Lymphoma in Autoimmune Hepatitis: A Large Retrospective Cohort Study.自身免疫性肝炎患者非霍奇金淋巴瘤风险增加:一项大型回顾性队列研究
J Clin Med. 2024 Oct 20;13(20):6258. doi: 10.3390/jcm13206258.
8
Targeting chronic liver diseases: Molecular markers, drug delivery strategies and future perspectives.靶向慢性肝脏疾病:分子标志物、药物传递策略和未来展望。
Int J Pharm. 2024 Jul 20;660:124381. doi: 10.1016/j.ijpharm.2024.124381. Epub 2024 Jun 23.
9
Changes in the etiology of liver cirrhosis and the corresponding management strategies.肝硬化病因的变化及相应的管理策略。
World J Hepatol. 2024 Feb 27;16(2):146-151. doi: 10.4254/wjh.v16.i2.146.
10
PD-1/PD-L1 immune checkpoint therapy demonstrates favorable safety profile in patients with autoimmune and cholestatic liver disease.PD-1/PD-L1 免疫检查点治疗在自身免疫性和胆汁淤积性肝病患者中表现出良好的安全性特征。
Front Immunol. 2024 Jan 10;14:1326078. doi: 10.3389/fimmu.2023.1326078. eCollection 2023.

本文引用的文献

1
Diagnosis and Management of Autoimmune Hepatitis in Adults and Children: 2019 Practice Guidance and Guidelines From the American Association for the Study of Liver Diseases.成人和儿童自身免疫性肝炎的诊断与管理:美国肝病研究协会2019年实践指南与规范
Hepatology. 2020 Aug;72(2):671-722. doi: 10.1002/hep.31065. Epub 2020 May 12.
2
The longitudinal integrated database for health insurance and labour market studies (LISA) and its use in medical research.医疗保险和劳动力市场研究的纵向综合数据库(LISA)及其在医学研究中的应用。
Eur J Epidemiol. 2019 Apr;34(4):423-437. doi: 10.1007/s10654-019-00511-8. Epub 2019 Mar 30.
3
Cohort profile: ESPRESSO (Epidemiology Strengthened by histoPathology Reports in Sweden).队列简介:ESPRESSO(瑞典组织病理学报告强化的流行病学研究)。
Clin Epidemiol. 2019 Jan 14;11:101-114. doi: 10.2147/CLEP.S191914. eCollection 2019.
4
The Swedish cause of death register.瑞典死亡原因登记册。
Eur J Epidemiol. 2017 Sep;32(9):765-773. doi: 10.1007/s10654-017-0316-1. Epub 2017 Oct 5.
5
Incidence and Determinants of Hepatocellular Carcinoma in Autoimmune Hepatitis: A Systematic Review and Meta-analysis.自身免疫性肝炎中肝细胞癌的发病率及决定因素:一项系统评价与荟萃分析
Clin Gastroenterol Hepatol. 2017 Aug;15(8):1207-1217.e4. doi: 10.1016/j.cgh.2017.02.006. Epub 2017 Feb 12.
6
The underreporting of hepatocellular carcinoma to the cancer register and a log-linear model to estimate a more correct incidence.肝癌向癌症登记处的漏报和对数线性模型估计更准确的发病率。
Hepatology. 2017 Mar;65(3):885-892. doi: 10.1002/hep.28775. Epub 2016 Sep 30.
7
EASL Clinical Practice Guidelines: Autoimmune hepatitis.欧洲肝脏研究学会临床实践指南:自身免疫性肝炎
J Hepatol. 2015 Oct;63(4):971-1004. doi: 10.1016/j.jhep.2015.06.030. Epub 2015 Sep 1.
8
Autoimmune hepatitis--Update 2015.自身免疫性肝炎——2015年更新
J Hepatol. 2015 Apr;62(1 Suppl):S100-11. doi: 10.1016/j.jhep.2015.03.005.
9
Hepatocellular and extrahepatic cancer in patients with autoimmune hepatitis--a long-term follow-up study in 634 Swedish patients.自身免疫性肝炎患者的肝细胞癌和肝外癌——对634名瑞典患者的长期随访研究
Scand J Gastroenterol. 2015 Feb;50(2):217-23. doi: 10.3109/00365521.2014.983154. Epub 2014 Dec 8.
10
Altered profile of human gut microbiome is associated with cirrhosis and its complications.人类肠道微生物群的改变与肝硬化及其并发症相关。
J Hepatol. 2014 May;60(5):940-7. doi: 10.1016/j.jhep.2013.12.019. Epub 2013 Dec 25.